Lisaftoclax

Latest Posts

SUZHOU, China and ROCKVILLE, Md., June 18, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a...

Market

Dwell from EHA 2024 | Ascentage Pharma Releases Up to date Knowledge of Lisaftoclax in Sufferers with R/R MM and AL Amyloidosis Highlighting Marked...

SUZHOU, China, and ROCKVILLE, Md., June 4, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a...

Market

Stay from ASCO 2024 | Ascentage Pharma Releases Up to date Knowledge Exhibiting Promising Efficacy and Security of Lisaftoclax in Sufferers with WM By...